0001209191-21-020248.txt : 20210312 0001209191-21-020248.hdr.sgml : 20210312 20210312173714 ACCESSION NUMBER: 0001209191-21-020248 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210115 FILED AS OF DATE: 20210312 DATE AS OF CHANGE: 20210312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klein Lawrence Otto CENTRAL INDEX KEY: 0001762583 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 21738754 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS AG STREET 2: 610 MAIN STREET 7TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-01-15 2021-01-20 0 0001674416 CRISPR Therapeutics AG CRSP 0001762583 Klein Lawrence Otto C/O CRISPR THERAPEUTICS, INC. 610 MAIN STREET CAMBRIDGE MA 02139 0 1 0 0 CBO & COO Common Shares 2021-01-15 4 M 0 16334 14.43 A 26942 D Common Shares 10608 D This amended Form 4 is being filed to correct the number of shares acquired on January 15, 2021. The original Form 4 filed on January 20, 2021 inadvertently included the wrong amount of shares beneficially owned after each transaction. This amended Form 4 is being filed to correct the number of shares beneficially owned following the transactions on January 15, 2021. /s/ Michael Esposito, attorney-in-fact 2021-03-12